Chapter 6: Idiopathic focal segmental glomerulosclerosis in adults

Kidney International Supplements

Volumn 2, Issue 2, 2012, Pages 181-185

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85096381157     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2012.19     Document Type: Article

References (46)

1. Chitalia, V.C., Wells, J.E., Robson, R.A., et al. Predicting renal survival in primary focal glomerulosclerosis from the time of presentation. Kidney Int 56 (1999), 2236–2242.
2. Troyanov, S., Wall, C.A., Miller, J.A., et al. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol 16 (2005), 1061–1068.
3. Chernin, G., Heeringa, S.F., Gbadegesin, R., et al. Low prevalence of NPHS2 mutations in African American children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 23 (2008), 1455–1460.
4. Ponticelli, C., Rizzoni, G., Edefonti, A., et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int 43 (1993), 1377–1384.
5. Meyrier, A., Condamin, M.C., Broneer, D., Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology. Clin Nephrol 35:Suppl 1 (1991), S37–S42.
6. Meyrier, A., Noel, L.H., Auriche, P., et al. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int 45 (1994), 1446–1456.
7. Jennette, J.C., Falk, R.J., Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis 16 (1990), 432–437.
8. D'Agati, V., Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23 (2003), 117–134.
9. Braden, G.L., Mulhern, J.G., O'Shea, M.H., et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis 35 (2000), 878–883.
10. Haas, M., Meehan, S.M., Karrison, T.G., et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976 to 1979 and 1995 to 1997. Am J Kidney Dis 30 (1997), 621–631.
11. Deegens, J.K., Steenbergen, E.J., Wetzels, J.F., Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth J Med 66 (2008), 3–12.
12. Deegens, J.K., Dijkman, H.B., Borm, G.F., et al. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 74 (2008), 1568–1576.
13. Aucella, F., De Bonis, P., Gatta, G., et al. Molecular analysis of NPHS2 and ACTN4 genes in a series of 33 Italian patients affected by adult-onset nonfamilial focal segmental glomerulosclerosis. Nephron Clin Pract 99 (2005), c31–c36.
14. Caridi, G., Bertelli, R., Scolari, F., et al. Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int, 64, 2003, 365.
15. Gigante, M., Pontrelli, P., Montemurno, E., et al. CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant 24 (2009), 1858–1864.
16. He, N., Zahirieh, A., Mei, Y., et al. Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2 (2007), 31–37.
17. Machuca, E., Hummel, A., Nevo, F., et al. Clinical and epidemiological assessment of steroid-resistant nephrotic syndrome associated with the NPHS2 R229Q variant. Kidney Int 75 (2009), 727–735.
18. Santin, S., Ars, E., Rossetti, S., et al. TRPC6 mutational analysis in a large cohort of patients with focal segmental glomerulosclerosis. Nephrol Dial Transplant 24 (2009), 3089–3096.
19. Santin, S., Garcia-Maset, R., Ruiz, P., et al. Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int 76 (2009), 1268–1276.
20. Genovese, G., Friedman, D.J., Ross, M.D., et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329 (2010), 841–845.
21. Cameron, J.S., Turner, D.R., Ogg, C.S., et al. The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10 (1978), 213–218.
22. Korbet, S.M., Schwartz, M.M., Lewis, E.J., Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 23 (1994), 773–783.
23. Velosa, J.A., Donadio, J.V. Jr, Holley, K.E., Focal sclerosing glomerulonephropathy: a clinicopathologic study. Mayo Clin Proc 50 (1975), 121–133.
24. Banfi, G., Moriggi, M., Sabadini, E., et al. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36 (1991), 53–59.
25. Cattran, D.C., Rao, P., Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32 (1998), 72–79.
26. Korbet, S.M., Treatment of primary focal segmental glomerulosclerosis. Kidney Int 62 (2002), 2301–2310.
27. Rydel, J.J., Korbet, S.M., Borok, R.Z., et al. Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis 25 (1995), 534–542.
28. Goumenos, D.S., Tsagalis, G., El Nahas, A.M., et al. Immunosuppressive treatment of idiopathic focal segmental glomerulosclerosis: a five-year follow-up study. Nephron Clin Pract 104 (2006), c75–c82.
29. Pei, Y., Cattran, D., Delmore, T., et al. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis. Regional Glomerulonephritis Registry Study. Am J Med 82 (1987), 938–944.
30. Stirling, C.M., Mathieson, P., Boulton-Jones, J.M., et al. Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units. QJM 98 (2005), 443–449.
31. Wehrmann, M., Bohle, A., Held, H., et al. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33 (1990), 115–122.
32. Caridi, G., Gigante, M., Ravani, P., et al. Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. Clin J Am Soc Nephrol 4 (2009), 1065–1072.
33. Beaufils, H., Alphonse, J.C., Guedon, J., et al. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases. Nephron 21 (1978), 75–85.
34. Praga, M., Martinez, M.A., Andres, A., et al. Acute renal failure and tubular dysfunction associated with minimal change nephrotic syndrome. Nephrol Dial Transplant 4 (1989), 914–916.
35. Deegens, J.K., Assmann, K.J., Steenbergen, E.J., et al. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?. Neth J Med 63 (2005), 393–398.
36. Gupta, K., Iskandar, S.S., Daeihagh, P., et al. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin. Nephrol Dial Transplant 23 (2008), 1595–1599.
37. Duncan, N., Dhaygude, A., Owen, J., et al. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant 19 (2004), 3062–3067.
38. Cattran, D.C., Alexopoulos, E., Heering, P., et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int 72 (2007), 1429–1447.
39. Shiiki, H., Nishino, T., Uyama, H., et al. Clinical and morphological predictors of renal outcome in adult patients with focal and segmental glomerulosclerosis (FSGS). Clin Nephrol 46 (1996), 362–368.
40. Braun, N., Schmutzler, F., Lange, C., et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database of Systematic Reviews, CD003233, 2008.
41. Cattran, D.C., Appel, G.B., Hebert, L.A., et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 56 (1999), 2220–2226.
42. Ghiggeri, G.M., Catarsi, P., Scolari, F., et al. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study. Clin Ther 26 (2004), 1411–1418.
43. Heering, P., Braun, N., Mullejans, R., et al. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis. Am J Kidney Dis 43 (2004), 10–18.
44. Ittel, T.H., Clasen, W., Fuhs, M., et al. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Clin Nephrol 44 (1995), 156–162.
45. Melocoton, T.L., Kamil, E.S., Cohen, A.H., et al. Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome. Am J Kidney Dis 18 (1991), 583–588.
46. Segarra, A., Vila, J., Pou, L., et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 17 (2002), 655–662.